{"id":"https://genegraph.clinicalgenome.org/r/0359c4b0-c3a1-4ed3-aea2-cb569a09d0aev1.0","type":"EvidenceStrengthAssertion","dc:description":"*MUC1* was FIRST reported in relation to autosomal dominant tubulointerstitial kidney disease (ADTKD-*MUC1*; OMIM: 174000) in 2013 (Kirby et al, PMID: 23396133). ADTKD-*MUC1* is characterized by slowly progressive tubulointerstitial kidney disease that leads to end-stage renal disease (ESRD) between ages 20-70 years. Age of end-stage kidney disease is variable and the reasons for this variability are unclear. Patients with ADTKD-*MUC1* have a bland urinary sediment without proteinuria or hematuria. The kidney ultrasound shows changes that are commonly found in chronic kidney disease and in general is not helpful in making this diagnosis. The key diagnostic parameter is a family history of chronic kidney disease. There are no other primary clinical manifestations of this disease (PMIDs: 24509297, 23946964; 32450155, 36250282). *MUC1* contains within the coding region a domain of multiple variable-number tandem repeats called the \"VNTR domain\" [NC_000001.10:g.(155160963_155162030)]. Mutational analysis of the *MUC1* VNTR region is extremely difficult due to its repetitive nature and high guanine/cytosine content (>80%) (PMIDs: 31116938, 27157321). In approximately 95% of cases the ADTKD-*MUC1* pathogenic variant is the insertion of an extra cytosine within a heptanucleotide cytosine tract of a VNTR unit (PMIDs: 23396133, 29967284, 29217307). Less common is the insertion of a different nucleotide (e.g., adenine, guanine). At least 7 unique variants in the VNTR domain of *MUC1*, and one variant located immediately before the VNTR (PMIDs: 29156055, 29967284), have been reported in humans. *MUC1* pathogenic variants result in the creation of the +1 frameshifted MUC1 protein (MUC1-fs). Expression of MUC1-fs is toxic to kidney cells and is responsible for slowly progressive chronic kidney disease, the sole manifestation of this disorder. Evidence supporting this gene-disease relationship includes case-level data, segregation data and experimental data. Summary of Case Level Data: 12 POINTS. Variants in this gene have been reported in at least 600 individuals (from more than 300 families) and segregated with the disease (PMIDs: 24509297, 23946964, 29217307, 29156055, 32450155, 36250282;). *MUC1* pathogenic variants causing ADTKD-*MUC1* result in the creation of the same frameshifted protein (MUC1-fs). This protein accumulates within the endoplasmic reticulum Golgi intermediate compartment (ERGIC) (PMIDs: 31348885, 29967284, 36250282). In individuals with ADTKD-*MUC1*, MUC1-fs is found in all cell types normally expressing MUC1 (including breast, gastric mucosa, and lung) (PMID: 29967284); however, clinical manifestations of disease only occur in the kidney, where its deposition leads to accelerated apoptosis, tubular cell death, nephron dropout, and progressive chronic kidney disease. Summary of Experimental Evidence: 4 POINTS. This gene-disease association is supported by immunohistochemical studies of MUC1-fs in patient kidney biopsies, urine derived cells from patients, kidney organoids derived from ADTKD-*MUC1* patients and a MUC1-fs knock-in mouse model (PMIDs: 29967284, 29217307, 31348885). In summary, *MUC1* is definitively associated with autosomal dominant tubulointerstitial kidney disease due to *MUC1* frameshifting mutations mainly in the VNTR (ADTKD-*MUC1*). This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Cystic and Ciliopathy Disorders GCEP Working Group on 01/13/2021 (SOP Version 8).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/0359c4b0-c3a1-4ed3-aea2-cb569a09d0ae","GCISnapshot":"https://genegraph.clinicalgenome.org/r/effa2b38-35c6-4071-b0d1-ce6970bb6ec1","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/effa2b38-35c6-4071-b0d1-ce6970bb6ec1_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10066","date":"2021-01-13T17:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/effa2b38-35c6-4071-b0d1-ce6970bb6ec1_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10066","date":"2023-04-03T13:20:02.883Z","role":"Publisher"}],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/effa2b38-35c6-4071-b0d1-ce6970bb6ec1_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/effa2b38-35c6-4071-b0d1-ce6970bb6ec1_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ba45b8ce-0c9b-4feb-a051-dbdb10c64f16","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e9d79176-fc40-47e9-af43-c46cba357b4c","type":"Finding","dc:description":"Mice carying mutant (MUC1-fs) allele developed progressive kidney disease while parental or wt (MUC1-wt) have no pathologic changes. The pathological changes detected in MUC1 mutant mice were similar to those observed in ADTKD-MUC1 patients: \ni) marked tubular dilations and interstitial fibrosis\nii) serum creatinin was mildly elevated in females (at 76 weeks), but not in males.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31348885","rdfs:label":"Knockin mice carrier human MUC1-fs allele","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/effa2b38-35c6-4071-b0d1-ce6970bb6ec1_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/605ea868-767b-4d92-87e8-1847a8026bc8","type":"EvidenceLine","dc:description":"Presence of MUC1-fs (mutated MUC1) in kidney tissue is one of the diagnostic marker of ADTKD due to mutations in MUC1.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a823e210-b1c2-428b-8dfe-9d187886649a","type":"Finding","dc:description":"In patients with the disease is present mutated MUC1 (frame shifted MUC1 = MUC1-fs) which is not present in healthy controls. \nMUC1-fs can be also detected in other tissues in patients with shifted mutation in VNTR of MUC1 gene (e.g. skin, breast).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23396133","rdfs:label":"IHC and IF of mutated MUC1 in kidney biopsy from patient","demonstrates":{"id":"cg:GeneExpressionB"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/73db2970-78f1-448c-a78b-ba9516fa3545","type":"EvidenceLine","dc:description":"Presence of MUC1-fs (mutated MUC1) in kidney tissue is one of the diagnostic marker of ADTKD due to mutations in MUC1. ","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2d49593a-b517-4960-896f-03fec3436c9e","type":"Finding","dc:description":"In patients with the disease is present mutated MUC1 (frame shifted MUC1 = MUC1-fs) which is not present in healthy controls. \nMUC1-fs can be also detected in other tissues in patients with shifted mutation in VNTR of MUC1 gene (e.g. skin, breast).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29967284","rdfs:label":"IHC of mutated MUC1 in kidney biopsy from patients ","demonstrates":{"id":"cg:GeneExpressionB"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/a6501410-b26f-4427-8fb9-de71bb7e4f37","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/487667e5-d916-4503-bedc-072186710441","type":"Finding","dc:description":"MUC1wt is physiologically expressed (and can be detected) by many different tissue in human body, e.g. kidney or urine derived cells...\nIn pateints with ADTKD-MUC1 can be also detect mutated form of MUC1 (MUC1-fs).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32450155","rdfs:label":"Detection of mutated MUC1 (MUC1-fs) in urine derived cells","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/62964795-caaa-415f-bca3-f61682adb946","type":"EvidenceLine","dc:description":"Positivity of MUC1-fs (mutated MUC1) in urinary cells is one of the diagnostic marker of ADTKD due to mutations in MUC1. MUC1-fs is detected specifically in patients with frame shift mutation(s) - either insertion (3n+1)nt or deletion (3n-1)nt in VNTR of MUC1. This MUC1-fs is never positive in healthy control.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d70b6462-7750-4994-b7b6-72d9faafb354","type":"Finding","dc:description":"Positivity of MUC1-fs (mutated MUC1) in urinary cells is one of the diagnostic marker of ADTKD due to mutations in MUC1. MUC1-fs is detected specifically in patients with frame shift mutation(s) - either insertion (3n+1)nt or deletion (3n-1)nt in VNTR of MUC1. This MUC1-fs is never positive in healthy control. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29967284","rdfs:label":"ICC detection of mut MUC1 in urinary cells from patients ","demonstrates":{"id":"cg:GeneExpressionB"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/effa2b38-35c6-4071-b0d1-ce6970bb6ec1_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bfe45a5f-0916-4396-9577-a25bd36df445","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bfe45a5f-0916-4396-9577-a25bd36df445_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Mutated MUC1 (MUC1-fs) was detected in urinary cells from patients from this family by immunohistochemical method using antibody against MUC1-fs. Used antibody specifically detects MUC1-fs which is synthesized after either insertion resulting in (3n+1) nucleotides or deletion resulting in (3n-1) nucleotides in VNTR of MUC1 (detailed in PMID: 29967284).","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/bfe45a5f-0916-4396-9577-a25bd36df445_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29967284","allele":{"id":"https://genegraph.clinicalgenome.org/r/d7d6bd3d-4eaa-4ece-96b6-a193ff7ab349","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"ENST00000611571.4(MUC1):c.522dup (p.Ala175SerfsTer833)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA1139655081"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/285eab47-b192-4f12-8082-f5e5833f2dff","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/285eab47-b192-4f12-8082-f5e5833f2dff_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Expression study of mutated MUC1 in IMCD-3 cells.\nHistopathiological analysis of mutated MUC1 in patientsÂ´ renal biopsy.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/285eab47-b192-4f12-8082-f5e5833f2dff_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29156055","allele":{"id":"https://genegraph.clinicalgenome.org/r/7f182051-19d0-4a89-b0e2-d3d04a8bc424","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"ENST00000611571.4(MUC1):c.221_222del (p.Gln74ArgfsTer933)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA1139655067"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/ce8293f6-ab9b-4939-9d57-952d4f806de0","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ce8293f6-ab9b-4939-9d57-952d4f806de0_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Mutated MUC1 (MUC1-fs) was detected in urinary cells from patients from this family by immunohistochemical method using antibody against MUC1-fs. Used antibody specifically detects MUC1-fs which is synthesized after either insertion resulting in (3n+1) nucleotides or deletion resulting in (3n-1) nucleotides in VNTR of MUC1 (detailed in PMID: 29967284).","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/ce8293f6-ab9b-4939-9d57-952d4f806de0_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29967284","allele":{"id":"https://genegraph.clinicalgenome.org/r/d7d6bd3d-4eaa-4ece-96b6-a193ff7ab349"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/721aa3c3-f4a9-43d2-a826-d7044b32e8bb","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/721aa3c3-f4a9-43d2-a826-d7044b32e8bb_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31509055","allele":{"id":"https://genegraph.clinicalgenome.org/r/dd6c344a-7689-4827-8876-2448c58a64c3","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000001.10:g.(155160963_155162030)insC","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/55830"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/443c4b36-f1b7-4c8b-bc2c-512652f0036a","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/443c4b36-f1b7-4c8b-bc2c-512652f0036a_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Kidney biopsy staining of MUC1-fs (mutated MUC1) and MUC1-wt.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/443c4b36-f1b7-4c8b-bc2c-512652f0036a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23396133","allele":{"id":"https://genegraph.clinicalgenome.org/r/dd6c344a-7689-4827-8876-2448c58a64c3"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/99d844a9-342f-4b86-9c93-e7a26d786b40","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/99d844a9-342f-4b86-9c93-e7a26d786b40_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Kidney biopsy staining oif MUC1-fs (mutated) and MUC1-wt.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/99d844a9-342f-4b86-9c93-e7a26d786b40_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23396133","allele":{"id":"https://genegraph.clinicalgenome.org/r/dd6c344a-7689-4827-8876-2448c58a64c3"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/effa2b38-35c6-4071-b0d1-ce6970bb6ec1_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bd52ad5f-1ed5-4de4-866e-5cd17d5cbcd5_proband_segregation","type":"FamilyCosegregation","dc:description":"1. Clinical features of the family were consistent with ADTKD-MUC1.\n2. Mutated MUC1 (MUC1-fs) was detected in urinary cells from patients from this family by immunohistochemical method using antibody against MUC1-fs. Used antibody specifically detects MUC1-fs which is synthesized after either insertion resulting in (3n+1) nucleotides or deletion resulting in (3n-1) nucleotides in VNTR of MUC1 (detailed in PMID: 29967284).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29967284","rdfs:label":"Family A","estimatedLodScore":2.11,"family":{"id":"https://genegraph.clinicalgenome.org/r/bd52ad5f-1ed5-4de4-866e-5cd17d5cbcd5","type":"Family","rdfs:label":"Family A","ethnicity":{"id":"cg:UnknownEthnicity"},"member":{"id":"https://genegraph.clinicalgenome.org/r/c99ce920-6dc8-44d0-8068-0bdec8ec2593","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29967284","rdfs:label":"A-II-2","allele":{"id":"https://genegraph.clinicalgenome.org/r/d7d6bd3d-4eaa-4ece-96b6-a193ff7ab349"},"detectionMethod":"Long-range PCR of the VNTR of MUC1 was performed, resulting in multiple repetitive DNA sequences of the VNTR. These sequences were then read with the Illumina HiSeq 2500 system. In this process, the individual nucleotide sequences derived from the PCR are sequenced in parallel, resulting in multiple, repeated sequence readings from the VNTR. The resulting sequence reads were analyzed directly, without mapping to the reference genome.","ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"Other","phenotypeFreeText":"Chronic kidney failure with a widely variable age of onset of end stage kidney disease ranging from 16 to >80 years, strong family history of chronic kidney diesase. Bland urinalysis, nonspecific ultrasound and biopsy findings, typically without medullary cysts. 24% prevalence of gout. Reduced penetrance and expresivity of the disease.","phenotypes":"obo:HP_0003259","previousTesting":false,"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/bfe45a5f-0916-4396-9577-a25bd36df445_variant_evidence_item"}}},"meetsInclusionCriteria":true,"phenotypeFreeText":"Chronic kidney failure with a widely variable age of onset of end stage kidney disease ranging from 16 to >80 years, strong family history of chronic kidney diesase. Bland urinalysis, nonspecific ultrasound and biopsy findings, typically without medullary cysts. 24% prevalence of gout. Reduced penetrance and expresivity of the disease.","phenotypePositiveAllelePositive":7,"phenotypes":"obo:HP_0003259","proband":{"id":"https://genegraph.clinicalgenome.org/r/c99ce920-6dc8-44d0-8068-0bdec8ec2593"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/fb1dc37a-c534-491e-9b3c-abff5e865c01_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29156055","rdfs:label":"Family A","estimatedLodScore":1.51,"family":{"id":"https://genegraph.clinicalgenome.org/r/fb1dc37a-c534-491e-9b3c-abff5e865c01","type":"Family","rdfs:label":"Family A","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/8ae5d8e1-141b-4178-bc9b-c1b9637d9b37","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29156055","rdfs:label":"IV-3","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":23,"allele":{"id":"https://genegraph.clinicalgenome.org/r/7f182051-19d0-4a89-b0e2-d3d04a8bc424"},"ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Chronic kidney failure with a widely variable age of onset of end stage kidney disease ranging from 16 to >80 years, strong family history of chronic kidney diesase. Bland urinalysis, nonspecific ultrasound and biopsy findings, typically without medullary cysts. 24% prevalence of gout. Reduced penetrance and expresivity of the disease.","phenotypes":"obo:HP_0003259","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/285eab47-b192-4f12-8082-f5e5833f2dff_variant_evidence_item"}}},"meetsInclusionCriteria":true,"phenotypeFreeText":"Chronic kidney failure with a widely variable age of onset of end stage kidney disease ranging from 16 to >80 years, strong family history of chronic kidney diesase. Bland urinalysis, nonspecific ultrasound and biopsy findings, typically without medullary cysts. 24% prevalence of gout. Reduced penetrance and expresivity of the disease.","phenotypePositiveAllelePositive":5,"phenotypes":"obo:HP_0003259","proband":{"id":"https://genegraph.clinicalgenome.org/r/8ae5d8e1-141b-4178-bc9b-c1b9637d9b37"},"sequencingMethod":{"id":"cg:AllGenesSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/389935fe-d8df-4e19-9cf4-29eeb0e283b5_proband_segregation","type":"FamilyCosegregation","dc:description":"Through linkage analysis was identified 2 Mb candidate region on ch1q.22 with LOD score 27. In critical region were excluded differences in CNVs, mutations in coding and non-coding regions by and large structural variation (del, ins, dup, inversions). At this point was concluded that the causal mutation is located in VNTR of MUC1 located in candidate region. The causal mutation was identified by clonning, subclonning, Sanger sequencing of individual subclones and de novo assembly for each MUC1 VNTR allele of affected individuals (in details described in PMID: 23396133).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23396133","rdfs:label":"Family 6","estimatedLodScore":1.2,"family":{"id":"https://genegraph.clinicalgenome.org/r/389935fe-d8df-4e19-9cf4-29eeb0e283b5","type":"Family","rdfs:label":"Family 6","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/dd706da2-d6ea-433f-87e0-d57e6b7fae58","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23396133","rdfs:label":"IV-3","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":27,"allele":{"id":"https://genegraph.clinicalgenome.org/r/dd6c344a-7689-4827-8876-2448c58a64c3"},"detectionMethod":"Linkage analysis: Affymetrix 6.0 platform, Linkage mapping was performed using the Merlin package under a rare, autosomal dominant model. \nADTKD-MUC1 in this family is caused by insertion of one cytosine within MUC1 VNTR, typically missed by NGS due to poor sequence coverage, because of VNTR of MUC1 is GC-rich and contains 20-120 repetitions (one repetition consist of 60-bp). The causal mutation was identified by clonning, subclonning, Sanger sequencing of individual subclones and de novo assembly for each MUC1 VNTR allele of affected individuals (in details described in PMID: 23396133).","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Linkage analysis","phenotypeFreeText":"Chronic kidney failure with a widely variable age of onset of end stage kidney disease ranging from 16 to >80 years, strong family history of chronic kidney diesase. Bland urinalysis, nonspecific ultrasound and biopsy findings, typically without medullary cysts. 24% prevalence of gout. Reduced penetrance and expresivity of the disease.","phenotypes":"obo:HP_0003259","previousTesting":false,"secondTestingMethod":"Other","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/ed4c3366-5d05-4586-827c-9e6c4b39cff7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23396133","allele":{"id":"https://genegraph.clinicalgenome.org/r/dd6c344a-7689-4827-8876-2448c58a64c3"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}}},"meetsInclusionCriteria":true,"phenotypeFreeText":"Chronic kidney failure with a widely variable age of onset of end stage kidney disease ranging from 16 to >80 years, strong family history of chronic kidney diesase. Bland urinalysis, nonspecific ultrasound and biopsy findings, typically without medullary cysts. 24% prevalence of gout. Reduced penetrance and expresivity of the disease.","phenotypePositiveAllelePositive":4,"phenotypes":"obo:HP_0003259","proband":{"id":"https://genegraph.clinicalgenome.org/r/dd706da2-d6ea-433f-87e0-d57e6b7fae58"},"publishedLodScore":27,"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/07096cde-8e81-4a74-b7da-84df0d161397_family_segregation","type":"FamilyCosegregation","dc:description":"Through linkage analysis was identified 2 Mb candidate region on ch1q.22 with LOD score 27. In critical region were excluded differences in CNVs, mutations in coding and non-coding regions by and large structural variation (del, ins, dup, inversions). At this point was concluded that the causal mutation is located in VNTR of MUC1 located in candidate region. The causal mutation was identified by clonning, subclonning, Sanger sequencing of individual subclones and de novo assembly for each MUC1 VNTR allele of affected individuals (in details described in PMID: 23396133).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23396133","rdfs:label":"Family 4","estimatedLodScore":1.2,"family":{"id":"https://genegraph.clinicalgenome.org/r/07096cde-8e81-4a74-b7da-84df0d161397","type":"Family","rdfs:label":"Family 4","ethnicity":{"id":"cg:NotHispanicOrLatino"}},"meetsInclusionCriteria":true,"phenotypeFreeText":"Chronic kidney failure with a widely variable age of onset of end stage kidney disease ranging from 16 to >80 years, strong family history of chronic kidney diesase. Bland urinalysis, nonspecific ultrasound and biopsy findings, typically without medullary cysts. 24% prevalence of gout. Reduced penetrance and expresivity of the disease.","phenotypePositiveAllelePositive":4,"publishedLodScore":27,"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/f91b5ff2-a6a3-4fee-a780-b8017e2da937_proband_segregation","type":"FamilyCosegregation","dc:description":"1. Clinical features of the family were consistent with ADTKD.\n2. Excluding of all known genes associated with ADTKD except MUC1.\n3. Availability of diagnostic method (probe extension assay - see in PMID: 27157321) specifically  detecting of prevalent mutation in VNTR of MUC1 (insertion of cytosin).\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31509055","rdfs:label":"Family 1_MUC1","estimatedLodScore":2.11,"family":{"id":"https://genegraph.clinicalgenome.org/r/f91b5ff2-a6a3-4fee-a780-b8017e2da937","type":"Family","rdfs:label":"Family 1_MUC1","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/fdfc3de3-12b6-4b39-b79e-a5ea7e0f6af6","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31509055","rdfs:label":"III-29","allele":{"id":"https://genegraph.clinicalgenome.org/r/dd6c344a-7689-4827-8876-2448c58a64c3"},"detectionMethod":"Probe-extension assay capable of distinguishing wt and insertion of cytosin (27dupC) or adenosin (28dupA) into VNTR of MUC1. Combination of PCR of VNTR, enzymatic digestion and using specific probe designed for detection of insertion. Products are sized by MALDI-TOF Mass spectrometry using Sequenom MassArray platform (for details see in PMID: 27157321).","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Other","phenotypeFreeText":"Chronic kidney failure with a widely variable age of onset of end stage kidney disease ranging from 16 to >80 years, strong family history of chronic kidney diesase. Bland urinalysis, nonspecific ultrasound and biopsy findings, typically without medullary cysts. 24% prevalence of gout. Reduced penetrance and expresivity of the disease.","phenotypes":"obo:HP_0003259","previousTesting":false,"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/721aa3c3-f4a9-43d2-a826-d7044b32e8bb_variant_evidence_item"}}},"meetsInclusionCriteria":true,"phenotypeFreeText":"Chronic kidney failure with a widely variable age of onset of end stage kidney disease ranging from 16 to >80 years, strong family history of chronic kidney diesase. Bland urinalysis, nonspecific ultrasound and biopsy findings, typically without medullary cysts. 24% prevalence of gout. Reduced penetrance and expresivity of the disease.","phenotypePositiveAllelePositive":7,"phenotypes":"obo:HP_0003259","proband":{"id":"https://genegraph.clinicalgenome.org/r/fdfc3de3-12b6-4b39-b79e-a5ea7e0f6af6"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/80d18895-6678-41b7-852b-fcac32157d74_proband_segregation","type":"FamilyCosegregation","dc:description":"1. Clinical features of the family were consistent with ADTKD-MUC1.\n2. Mutated MUC1 (MUC1-fs) was detected in urinary cells from patients from this family by immunohistochemical method using antibody against MUC1-fs. Used antibody specifically detects MUC1-fs which is synthesized after either insertion resulting in (3n+1) nucleotides or deletion resulting in (3n-1) nucleotides in VNTR of MUC1 (detailed in PMID: 29967284).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29967284","rdfs:label":"Family F","estimatedLodScore":1.2,"family":{"id":"https://genegraph.clinicalgenome.org/r/80d18895-6678-41b7-852b-fcac32157d74","type":"Family","rdfs:label":"Family F","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/4c6eb410-1cf1-4de3-87b8-33e58ae51eac","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29967284","rdfs:label":"F-IV-2","ageType":"AgeAtReport","ageUnit":"Years","ageValue":26,"allele":{"id":"https://genegraph.clinicalgenome.org/r/6a7b0a2b-9754-4a05-bcd4-cc934a41a6ac","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"ENST00000611571.4(MUC1):c.545dup (p.Asp183GlyfsTer825)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA1139655083"}},"detectionMethod":"Long-range PCR of the VNTR of MUC1 was performed, resulting in multiple repetitive DNA sequences of the VNTR. These sequences were then read with the Illumina HiSeq 2500 system. In this process, the individual nucleotide sequences derived from the PCR are sequenced in parallel, resulting in multiple, repeated sequence readings from the VNTR. The resulting sequence reads were analyzed directly, without mapping to the reference genome.","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Other","phenotypeFreeText":"Chronic kidney failure with a widely variable age of onset of end stage kidney disease ranging from 16 to >80 years, strong family history of chronic kidney diesase. Bland urinalysis, nonspecific ultrasound and biopsy findings, typically without medullary cysts. 24% prevalence of gout. Reduced penetrance and expresivity of the disease.","phenotypes":"obo:HP_0003259","previousTesting":false,"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/a8d6157f-b94d-46db-b2bd-18eb427b9c8b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29967284","allele":{"id":"https://genegraph.clinicalgenome.org/r/6a7b0a2b-9754-4a05-bcd4-cc934a41a6ac"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}}},"meetsInclusionCriteria":true,"phenotypeFreeText":"Chronic kidney failure with a widely variable age of onset of end stage kidney disease ranging from 16 to >80 years, strong family history of chronic kidney diesase. Bland urinalysis, nonspecific ultrasound and biopsy findings, typically without medullary cysts. 24% prevalence of gout. Reduced penetrance and expresivity of the disease.","phenotypePositiveAllelePositive":4,"phenotypes":"obo:HP_0003259","proband":{"id":"https://genegraph.clinicalgenome.org/r/4c6eb410-1cf1-4de3-87b8-33e58ae51eac"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/4288d27a-54ca-42f7-b2af-250cbdc51352_proband_segregation","type":"FamilyCosegregation","dc:description":"ADTKD-MUC1 in this family is caused by insertion of one cytosine within MUC1 VNTR, typically missed by NGS due to poor sequence coverage, because of VNTR of MUC1 is GC-rich and contains 20-120 repetitions (one repetition consist of 60-bp). The causal mutation was identified by clonning, subclonning, Sanger sequencing of individual subclones and de novo assembly for each MUC1 VNTR allele of affected individuals (in details described in PMID: 23396133).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23396133","rdfs:label":"Family 1","estimatedLodScore":3.01,"family":{"id":"https://genegraph.clinicalgenome.org/r/4288d27a-54ca-42f7-b2af-250cbdc51352","type":"Family","rdfs:label":"Family 1","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/25820f28-629f-4a96-b106-eefe6e5c50e6","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23396133","rdfs:label":"IV-2","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":54,"allele":{"id":"https://genegraph.clinicalgenome.org/r/dd6c344a-7689-4827-8876-2448c58a64c3"},"detectionMethod":"Linkage analysis: Affymetrix 6.0 platform, Linkage mapping was performed using the Merlin package under a rare, autosomal dominant model. ","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Linkage analysis","phenotypeFreeText":"Chronic kidney failure with a widely variable age of onset of end stage kidney disease ranging from 16 to >80 years, strong family history of chronic kidney diesase. Bland urinalysis, nonspecific ultrasound and biopsy findings, typically without medullary cysts. 24% prevalence of gout. Reduced penetrance and expresivity of the disease.","phenotypes":"obo:HP_0003259","previousTesting":false,"secondTestingMethod":"Other","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/443c4b36-f1b7-4c8b-bc2c-512652f0036a_variant_evidence_item"}}},"meetsInclusionCriteria":true,"phenotypeFreeText":"Chronic kidney failure with a widely variable age of onset of end stage kidney disease ranging from 16 to >80 years, strong family history of chronic kidney diesase. Bland urinalysis, nonspecific ultrasound and biopsy findings, typically without medullary cysts. 24% prevalence of gout. Reduced penetrance and expresivity of the disease.","phenotypePositiveAllelePositive":10,"phenotypes":"obo:HP_0003259","proband":{"id":"https://genegraph.clinicalgenome.org/r/25820f28-629f-4a96-b106-eefe6e5c50e6"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/d41e108d-77c9-430b-9218-685d8ccb6d14_proband_segregation","type":"FamilyCosegregation","dc:description":"1. Clinical features of the family were consistent with ADTKD-MUC1.\n2. Mutated MUC1 (MUC1-fs) was detected in urinary cells from patients from this family by immunohistochemical method using antibody against MUC1-fs. Used antibody specifically detects MUC1-fs which is synthesized after either insertion resulting in (3n+1) nucleotides or deletion resulting in (3n-1) nucleotides in VNTR of MUC1 (detailed in PMID: 29967284).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29967284","rdfs:label":"Family B","estimatedLodScore":0.3,"family":{"id":"https://genegraph.clinicalgenome.org/r/d41e108d-77c9-430b-9218-685d8ccb6d14","type":"Family","rdfs:label":"Family B","ethnicity":{"id":"cg:UnknownEthnicity"},"member":{"id":"https://genegraph.clinicalgenome.org/r/0076f1de-4013-4863-be13-7bd8221b7bb3","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29967284","rdfs:label":"B-II-2","ageType":"AgeAtReport","ageUnit":"Years","ageValue":19,"allele":{"id":"https://genegraph.clinicalgenome.org/r/d7d6bd3d-4eaa-4ece-96b6-a193ff7ab349"},"detectionMethod":"Long-range PCR of the VNTR of MUC1 was performed, resulting in multiple repetitive DNA sequences of the VNTR. These sequences were then read with the Illumina HiSeq 2500 system. In this process, the individual nucleotide sequences derived from the PCR are sequenced in parallel, resulting in multiple, repeated sequence readings from the VNTR. The resulting sequence reads were analyzed directly, without mapping to the reference genome.","ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"Other","phenotypeFreeText":"Chronic kidney failure with a widely variable age of onset of end stage kidney disease ranging from 16 to >80 years, strong family history of chronic kidney diesase. Bland urinalysis, nonspecific ultrasound and biopsy findings, typically without medullary cysts. 24% prevalence of gout. Reduced penetrance and expresivity of the disease.","phenotypes":"obo:HP_0003259","previousTesting":false,"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/ce8293f6-ab9b-4939-9d57-952d4f806de0_variant_evidence_item"}}},"meetsInclusionCriteria":true,"phenotypeFreeText":"Chronic kidney failure with a widely variable age of onset of end stage kidney disease ranging from 16 to >80 years, strong family history of chronic kidney diesase. Bland urinalysis, nonspecific ultrasound and biopsy findings, typically without medullary cysts. 24% prevalence of gout. Reduced penetrance and expresivity of the disease.","phenotypePositiveAllelePositive":1,"phenotypes":"obo:HP_0003259","proband":{"id":"https://genegraph.clinicalgenome.org/r/0076f1de-4013-4863-be13-7bd8221b7bb3"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/fc56f333-5ac8-4a07-8a2a-e55fd9a2f881_proband_segregation","type":"FamilyCosegregation","dc:description":"Through linkage analysis was identified 2 Mb candidate region on ch1q.22 with LOD score 27. In critical region were excluded differences in CNVs, mutations in coding and non-coding regions by and large structural variation (del, ins, dup, inversions). At this point was concluded that the causal mutation is located in VNTR of MUC1 located in candidate region. The causal mutation was identified by clonning, subclonning, Sanger sequencing of individual subclones and de novo assembly for each MUC1 VNTR allele of affected individuals (in details described in PMID: 23396133).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23396133","rdfs:label":"Family 2","estimatedLodScore":2.41,"family":{"id":"https://genegraph.clinicalgenome.org/r/fc56f333-5ac8-4a07-8a2a-e55fd9a2f881","type":"Family","rdfs:label":"Family 2","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/b17ae4fe-be4c-430e-b476-86c20f0e17af","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23396133","rdfs:label":"IV-5","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":43,"allele":{"id":"https://genegraph.clinicalgenome.org/r/dd6c344a-7689-4827-8876-2448c58a64c3"},"detectionMethod":"Linkage analysis: Affymetrix 6.0 platform, Linkage mapping was performed using the Merlin package under a rare, autosomal dominant model. ","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Linkage analysis","phenotypeFreeText":"Chronic kidney failure with a widely variable age of onset of end stage kidney disease ranging from 16 to >80 years, strong family history of chronic kidney diesase. Bland urinalysis, nonspecific ultrasound and biopsy findings, typically without medullary cysts. 24% prevalence of gout. Reduced penetrance and expresivity of the disease.","phenotypes":"obo:HP_0003259","previousTesting":false,"secondTestingMethod":"Other","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/afa4344f-3560-45ca-b4cf-21c213f6bd7c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23396133","allele":{"id":"https://genegraph.clinicalgenome.org/r/dd6c344a-7689-4827-8876-2448c58a64c3"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}}},"meetsInclusionCriteria":true,"phenotypeFreeText":"Chronic kidney failure with a widely variable age of onset of end stage kidney disease ranging from 16 to >80 years, strong family history of chronic kidney diesase. Bland urinalysis, nonspecific ultrasound and biopsy findings, typically without medullary cysts. 24% prevalence of gout. Reduced penetrance and expresivity of the disease.","phenotypePositiveAllelePositive":8,"phenotypes":"obo:HP_0003259","proband":{"id":"https://genegraph.clinicalgenome.org/r/b17ae4fe-be4c-430e-b476-86c20f0e17af"},"publishedLodScore":27,"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/27dcb39c-df28-4a13-9c9c-44c23b8f61c3_proband_segregation","type":"FamilyCosegregation","dc:description":"Through linkage analysis was identified 2 Mb candidate region on ch1q.22 with LOD score 27. In critical region were excluded differences in CNVs, mutations in coding and non-coding regions by and large structural variation (del, ins, dup, inversions). At this point was concluded that the causal mutation is located in VNTR of MUC1 located in candidate region. The causal mutation was identified by clonning, subclonning, Sanger sequencing of individual subclones and de novo assembly for each MUC1 VNTR allele of affected individuals (in details described in PMID: 23396133).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23396133","rdfs:label":"Family 5","estimatedLodScore":1.51,"family":{"id":"https://genegraph.clinicalgenome.org/r/27dcb39c-df28-4a13-9c9c-44c23b8f61c3","type":"Family","rdfs:label":"Family 5","ethnicity":{"id":"cg:UnknownEthnicity"},"member":{"id":"https://genegraph.clinicalgenome.org/r/aa918b10-b6e4-400d-8fd0-08d4085396a2","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23396133","rdfs:label":"IV-5","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":22,"allele":{"id":"https://genegraph.clinicalgenome.org/r/dd6c344a-7689-4827-8876-2448c58a64c3"},"detectionMethod":"Linkage analysis: Affymetrix 6.0 platform, Linkage mapping was performed using the Merlin package under a rare, autosomal dominant model. \nADTKD-MUC1 in this family is caused by insertion of one cytosine within MUC1 VNTR, typically missed by NGS due to poor sequence coverage, because of VNTR of MUC1 is GC-rich and contains 20-120 repetitions (one repetition consist of 60-bp). The causal mutation was identified by clonning, subclonning, Sanger sequencing of individual subclones and de novo assembly for each MUC1 VNTR allele of affected individuals (in details described in PMID: 23396133).","ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"Linkage analysis","phenotypeFreeText":"Chronic kidney failure with a widely variable age of onset of end stage kidney disease ranging from 16 to >80 years, strong family history of chronic kidney diesase. Bland urinalysis, nonspecific ultrasound and biopsy findings, typically without medullary cysts. 24% prevalence of gout. Reduced penetrance and expresivity of the disease.","phenotypes":"obo:HP_0003259","previousTesting":false,"secondTestingMethod":"Other","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/d0c89e01-ccb4-4424-87c0-9b63e3af19de_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23396133","allele":{"id":"https://genegraph.clinicalgenome.org/r/dd6c344a-7689-4827-8876-2448c58a64c3"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}}},"phenotypeFreeText":"Chronic kidney failure with a widely variable age of onset of end stage kidney disease ranging from 16 to >80 years, strong family history of chronic kidney diesase. Bland urinalysis, nonspecific ultrasound and biopsy findings, typically without medullary cysts. 24% prevalence of gout. Reduced penetrance and expresivity of the disease.","phenotypePositiveAllelePositive":5,"phenotypes":"obo:HP_0003259","proband":{"id":"https://genegraph.clinicalgenome.org/r/aa918b10-b6e4-400d-8fd0-08d4085396a2"},"publishedLodScore":27,"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/8d6aba62-c695-496f-9725-19cc4056ecdf_proband_segregation","type":"FamilyCosegregation","dc:description":"1. Clinical features of the family were consistent with ADTKD-MUC1.\n2. Mutated MUC1 (MUC1-fs) was detected in urinary cells from patients from this family by immunohistochemical method using antibody against MUC1-fs. Used antibody specifically detects MUC1-fs which is synthesized after either insertion resulting in (3n+1) nucleotides or deletion resulting in (3n-1) nucleotides in VNTR of MUC1 (detailed in PMID: 29967284).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29967284","rdfs:label":"Family C","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/8d6aba62-c695-496f-9725-19cc4056ecdf","type":"Family","rdfs:label":"Family C","ethnicity":{"id":"cg:UnknownEthnicity"},"member":{"id":"https://genegraph.clinicalgenome.org/r/51d0e886-f276-4646-9a6d-f92a72615109","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29967284","rdfs:label":"C-III-6","ageType":"AgeAtReport","ageUnit":"Years","ageValue":32,"allele":{"id":"https://genegraph.clinicalgenome.org/r/125311b5-9671-4470-840f-f6e16915616b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"ENST00000611571.4(MUC1):c.520_521insG (p.Pro174ArgfsTer834)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA1139655082"}},"detectionMethod":"Long-range PCR of the VNTR of MUC1 was performed, resulting in multiple repetitive DNA sequences of the VNTR. These sequences were then read with the Illumina HiSeq 2500 system. In this process, the individual nucleotide sequences derived from the PCR are sequenced in parallel, resulting in multiple, repeated sequence readings from the VNTR. The resulting sequence reads were analyzed directly, without mapping to the reference genome.","ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"Other","phenotypeFreeText":"Chronic kidney failure with a widely variable age of onset of end stage kidney disease ranging from 16 to >80 years, strong family history of chronic kidney diesase. Bland urinalysis, nonspecific ultrasound and biopsy findings, typically without medullary cysts. 24% prevalence of gout. Reduced penetrance and expresivity of the disease.","phenotypes":"obo:HP_0003259","previousTesting":false,"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/62d185cb-6db7-440e-b520-f7d7eb069b8d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29967284","allele":{"id":"https://genegraph.clinicalgenome.org/r/125311b5-9671-4470-840f-f6e16915616b"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}}},"meetsInclusionCriteria":true,"phenotypeFreeText":"Chronic kidney failure with a widely variable age of onset of end stage kidney disease ranging from 16 to >80 years, strong family history of chronic kidney diesase. Bland urinalysis, nonspecific ultrasound and biopsy findings, typically without medullary cysts. 24% prevalence of gout. Reduced penetrance and expresivity of the disease.","phenotypePositiveAllelePositive":2,"phenotypes":"obo:HP_0003259","proband":{"id":"https://genegraph.clinicalgenome.org/r/51d0e886-f276-4646-9a6d-f92a72615109"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/941abf2a-90c7-4f43-b403-d25861a9ea95_proband_segregation","type":"FamilyCosegregation","dc:description":"Through linkage analysis was identified 2 Mb candidate region on ch1q.22 with LOD score 27. In critical region were excluded differences in CNVs, mutations in coding and non-coding regions by and large structural variation (del, ins, dup, inversions). At this point was concluded that the causal mutation is located in VNTR of MUC1 located in candidate region. The causal mutation was identified by clonning, subclonning, Sanger sequencing of individual subclones and de novo assembly for each MUC1 VNTR allele of affected individuals (in details described in PMID: 23396133).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23396133","rdfs:label":"Family 3","estimatedLodScore":3.61,"family":{"id":"https://genegraph.clinicalgenome.org/r/941abf2a-90c7-4f43-b403-d25861a9ea95","type":"Family","rdfs:label":"Family 3","ethnicity":{"id":"cg:UnknownEthnicity"},"member":{"id":"https://genegraph.clinicalgenome.org/r/a09a848e-6819-43c3-ae8b-e7401c1a7d78","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23396133","rdfs:label":"III-13","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":38,"allele":{"id":"https://genegraph.clinicalgenome.org/r/dd6c344a-7689-4827-8876-2448c58a64c3"},"detectionMethod":"Linkage analysis: Affymetrix 6.0 platform, Linkage mapping was performed using the Merlin package under a rare, autosomal dominant model. \nADTKD-MUC1 in this family is caused by insertion of one cytosine within MUC1 VNTR, typically missed by NGS due to poor sequence coverage, because of VNTR of MUC1 is GC-rich and contains 20-120 repetitions (one repetition consist of 60-bp). The causal mutation was identified by clonning, subclonning, Sanger sequencing of individual subclones and de novo assembly for each MUC1 VNTR allele of affected individuals (in details described in PMID: 23396133).","ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"Linkage analysis","phenotypeFreeText":"Chronic kidney failure with a widely variable age of onset of end stage kidney disease ranging from 16 to >80 years, strong family history of chronic kidney diesase. Bland urinalysis, nonspecific ultrasound and biopsy findings, typically without medullary cysts. 24% prevalence of gout. Reduced penetrance and expresivity of the disease.","phenotypes":"obo:HP_0003259","previousTesting":false,"secondTestingMethod":"Other","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/99d844a9-342f-4b86-9c93-e7a26d786b40_variant_evidence_item"}}},"meetsInclusionCriteria":true,"phenotypeFreeText":"Chronic kidney failure with a widely variable age of onset of end stage kidney disease ranging from 16 to >80 years, strong family history of chronic kidney diesase. Bland urinalysis, nonspecific ultrasound and biopsy findings, typically without medullary cysts. 24% prevalence of gout. Reduced penetrance and expresivity of the disease.","phenotypePositiveAllelePositive":12,"phenotypes":"obo:HP_0003259","proband":{"id":"https://genegraph.clinicalgenome.org/r/a09a848e-6819-43c3-ae8b-e7401c1a7d78"},"publishedLodScore":27,"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/d0c89e01-ccb4-4424-87c0-9b63e3af19de","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d0c89e01-ccb4-4424-87c0-9b63e3af19de_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Kidney biopsy staining oif MUC1-fs (mutated) and MUC1-wt.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/d0c89e01-ccb4-4424-87c0-9b63e3af19de_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/62d185cb-6db7-440e-b520-f7d7eb069b8d","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/62d185cb-6db7-440e-b520-f7d7eb069b8d_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Mutated MUC1 (MUC1-fs) was detected in urinary cells from patients from this family by immunohistochemical method using antibody against MUC1-fs. Used antibody specifically detects MUC1-fs which is synthesized after either insertion resulting in (3n+1) nucleotides or deletion resulting in (3n-1) nucleotides in VNTR of MUC1 (detailed in PMID: 29967284).","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/62d185cb-6db7-440e-b520-f7d7eb069b8d_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/ed4c3366-5d05-4586-827c-9e6c4b39cff7","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ed4c3366-5d05-4586-827c-9e6c4b39cff7_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Kidney biopsy staining oif MUC1-fs (mutated) and MUC1-wt.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/ed4c3366-5d05-4586-827c-9e6c4b39cff7_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/afa4344f-3560-45ca-b4cf-21c213f6bd7c","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/afa4344f-3560-45ca-b4cf-21c213f6bd7c_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Kidney biopsy staining oif MUC1-fs (mutated) and MUC1-wt.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/afa4344f-3560-45ca-b4cf-21c213f6bd7c_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/a8d6157f-b94d-46db-b2bd-18eb427b9c8b","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a8d6157f-b94d-46db-b2bd-18eb427b9c8b_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Mutated MUC1 (MUC1-fs) was detected in urinary cells from patients from this family by immunohistochemical method using antibody against MUC1-fs. Used antibody specifically detects MUC1-fs which is synthesized after either insertion resulting in (3n+1) nucleotides or deletion resulting in (3n-1) nucleotides in VNTR of MUC1 (detailed in PMID: 29967284).","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/a8d6157f-b94d-46db-b2bd-18eb427b9c8b_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12}],"evidenceStrength":"Definitive","sequence":6081,"specifiedBy":"GeneValidityCriteria8","strengthScore":16,"subject":{"id":"https://genegraph.clinicalgenome.org/r/UkxCy55foAQ","type":"GeneValidityProposition","disease":"obo:MONDO_0020726","gene":"hgnc:7508","modeOfInheritance":"obo:HP_0000006"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_effa2b38-35c6-4071-b0d1-ce6970bb6ec1-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}